Saros Therapeutics is working to enhance patients' response to immunotherapy.
Saros Therapeutics has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in September 2023.
Saros Therapeutics's investors include National Cancer Institute.
Saros Therapeutics is headquartered in Chicago, United States.
Saros Therapeutics is working to enhance patients' response to immunotherapy.
Saros Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Saros Therapeutics — Funding & Investors." VCBacked, September 22, 2023, https://www.vcbacked.co/company/saros-therapeutics. Accessed November 19, 2026.
VCBacked. (2023). Saros Therapeutics — Funding & Investors. Retrieved November 19, 2026, from https://www.vcbacked.co/company/saros-therapeutics
{{cite web |title=Saros Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/saros-therapeutics |website=VCBacked |access-date=November 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Saros Therapeutics? Request a listing update